JOSEPH MORABITO: Open Payments
NPI 1598038507 · LIVERPOOL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,151 in 55 payments from 17 companies in 2025. Trend: 2023 $372 · 2024 $753 · 2025 $1,151
Food & beverage: $1,151
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $202 |
| GlaxoSmithKline, LLC. | 10 | $167 |
| AstraZeneca Pharmaceuticals LP | 9 | $150 |
| INTUITIVE SURGICAL, INC. | 1 | $110 |
| PFIZER INC. | 5 | $101 |
| Phathom Pharmaceuticals, Inc. | 4 | $97 |
| Novo Nordisk Inc | 5 | $97 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Gilead Sciences, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
Products named: TRELEGY ELLIPTA, Da Vinci Surgical System, QULIPTA, VRAYLAR, BREZTRI, VOQUEZNA, Rybelsus, NURTEC ODT.
Industry payments across NY — which companies pay providers there.
